
News
Home>News & Events>Publications>C-Path>Alzheimer’s and Parkinson’s Diseases Face Common Challenges in Therapeutic Development: Role of the Precompetitive Consortium, Coalition Against Major Diseases
86
Related Posts
-
Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson’s disease clinical trials: a disease progression modeling analysis
-
Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients
-
Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease
-
Development of a Patient-Reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase
-
Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease